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Abstract
RANTES is a key chemokine for atherosclerosis, and obesity is associated with
progression of atherosclerosis. Substance P (SP) increases glucose uptake and
accumulation of lipids in adipocytes, and SP may upregulate RANTES
expression. This study investigated the mechanism of RANTES expression by
human M1 macrophages stimulated with SP.
SP upregulated RANTES protein expression, whereas aprepitant (an NK1R
antagonist) blunted this response. Pretreatment of macrophages with BIRB796 (a
combined p38g/p38d inhibitor) led to a signiﬁcant decrease of RANTES
expression. Next, we investigated the eﬀect of several NK1R internalization
factors on RANTES expression, including GRK2, b-arrestin 2, dynamin, ROCK,
and TGFb1. Exposure of macrophages to SP upregulated TGFb1 expression.
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level after stimulation by SP, whereas TGFb1/2/3 siRNA or dynasore (a dynamin
inhibitor) decreased RANTES and Y-27632 (a ROCK inhibitor) had no eﬀect.
Surprisingly, silencing of transcription factor speciﬁcity protein 1 (Sp1) or
inhibition of Sp1 activity by mithramycin led to signiﬁcant upregulation of
TGFb1 protein and corresponding enhancement of RANTES expression (by
ELISA or western blotting), whereas siRNA for C/EBPb attenuated expression of
both TGFb1 and RANTES. Next, we investigated transcriptional cross-talk among
Sp1 and C/EBPb, TIF1b, or Fli-1 in relation to RANTES expression. Compared
with TIF1b or Fli-1 siRNA, C/EBPb siRNA showed signiﬁcantly stronger
inhibition of RANTES production by Sp1 siRNA-transfected macrophages after
stimulation with SP.
In conclusion, transcription factor Sp1 engages in cross-talk with C/EBPb and
modulates TGFb1 production to negatively regulate RANTES expression in
macrophages stimulated with SP.
In conclusion, cross-talk between the transcription factor Sp1 and C/EBPb
modulates TGFb1 production to negatively regulate expression of the atherogenic
chemokine RANTES in SP-stimulated macrophages, while RANTES is
upregulated by SP via the p38gdMAPK/C/EBPb/TGFb1 signaling pathway.
Keywords: Cell biology, Molecular biology
1. Introduction
Obesity is known to be an important risk factor for atherosclerosis [1]. Inﬂammatory
cell recruitment to the intima is an initial step in atherosclerosis, and this process is
triggered by chemokines produced by locally activated inﬂammatory cells. Accumu-
lation of monocyte-derived macrophages in the vessel wall is a hallmark of the
atherosclerotic process [2], and M1 macrophages are the dominant type linked to
progression of atherosclerotic disease [3]. Regulated on activation, normal T cell ex-
pressed and secreted (RANTES) is produced by M1 macrophages [4] and has been
shown to be involved in progression of atherosclerosis [5]. Insulin resistance asso-
ciated with obesity is a major risk factor for cardiovascular disease. Substance P (SP)
enhances insulin resistance at the adipocyte level [6] and increases glucose uptake,
resulting in accumulation of lipids in adipocytes [7]. Thus, SP may promote expan-
sion of the fat mass [8]. We previously reported that human visceral adipocytes ob-
tained from subjects with a body mass index (BMI) >30 kg/m2 show higher
production of SP than adipocytes from subjects with a BMI <30 kg/m2 [9], suggest-
ing that visceral adipocytes could be a source of SP. Expression of various chemo-
kines is upregulated by SP [10], and recruitment of inﬂammatory cells to the
vascular intima by chemokines is essential to the development and progression of
atherosclerosis. Therefore, SP may represent a link between visceral adipocytes
2 https://doi.org/10.1016/j.heliyon.2018.e00679
2405-8440/ 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Article Nowe00679
and atherosclerosis. Accordingly, we investigated the mechanisms regulating
expression of the atherogenic chemokine/ligand 5 CCL5/RANTES by human M1
macrophages after stimulation with SP.
Neurokinin 1 receptor (NK1R) is the receptor for SP. Recycling and resensitization
of NK1R require its internalization in response to SP. Understanding the molecular
mechanisms underlying SP-induced internalization of NK1R is important because of
the essential role of signal transduction in traﬃcking of this receptor. During inter-
nalization, NK1R signaling not only occurs at the plasma membrane, but also the
endosomal membrane. SP-induced internalization of NK1R is mediated by the
GTPase dynamin [11, 12], which is essential for clathrin-mediated endocytosis of
NK1R via membrane ﬁssion [13], and NK1R is colocalized with dynamin on the
plasma membrane. The b-arrestins also serve as adaptors during SP-mediated inter-
nalization of NK1R [14].
Interestingly, transforming growth factor b1 (TGFb1) has been shown to modulate
phosphorylation of NK1R and delay its internalization after activation by SP [15,
16], with this delay of NK1R internalization leading to marked enhancement of
SP-induced cellular signaling [17]. It also has been reported that SP upregulates
TGFb1 at the mRNA and protein levels [18], while TGFb1 downregulates NK1
R gene expression [20]. Various transcription factors, such as speciﬁcity protein 1
(Sp1) and CCAAT-enhancer-binding protein b (C/EBPb), induce TGFb1 promoter
activity [19, 20]. Therefore, we also investigated the inﬂuence of Sp1 and C/EBPb
on TGFb1 expression by macrophages in response to SP stimulation.
2. Materials and methods
2.1. Ethics statement
Human peripheral blood samples were obtained from healthy volunteers and this
study was approved by the Institutional Review Board of Kumamoto Health Science
University. Written informed consent was obtained from all of the volunteers.
2.2. Chemicals and reagents
Human recombinant GM-CSF was obtained from Tocris Bioscience, Bristol, UK.
Substance P (Peptide Institute Inc., Osaka, Japan), SB203580 (Wako, Kanagawa,
Japan), aprepitant (Cayman Chemical, Ann Arbor, Michigan), PD98059 (Wako),
BIRB796 (Axon Medchem, Groningen, Netherlands), U0216 (Promega Corpora-
tion, Madison, WI) and mithramycin (Abcam, Cambridge, UK) were employed to
investigate the intracellular signaling pathways involved in RANTES production.
The actions of all these reagents are summarized in Table 1.
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2.3. Isolation of adherent monocytes from peripheral blood
mononuclear cells
Lymphocyte medium for thawing (BBLYMPH1) was obtained from Zen-Bio, Inc.
(Research Triangle Park, NC). Peripheral blood mononuclear cells (PBMCs) were
isolated as described previously [21]. Brieﬂy, heparinized blood samples were ob-
tained from nonsmoking healthy volunteers and were diluted 1:1 with pyrogen-
free saline. Further, PBMCs were isolated immediately after collection using Lym-
phoprep gradients (Axis-Shield PoC As, Norway). Then, cells were suspended with
BBLYMPH1 and incubated for 3 hrs. For monocyte isolation by plastic adherence,
1 106 cells per well were distributed into 12-well plates (Corning Inc. Costar, NY,
USA) and allowed to adhere in a 5% CO2 incubator at 37 C for 2 hrs and washed 3
times with warm phosphate-buﬀered saline (PBS) to remove nonadherent cells.
Then, monocytes were cultured in complete medium consisting of RPMI 1640 sup-
plemented with 10% heat-inactivated fetal calf serum (FCS) and 10  103 mg/L
gentamicin at 37 C in 5% CO2 humidiﬁed air. The adherent monocytes were recov-
ered with a cell scraper. The purity of monocytes was evaluated by ﬂuorescent stain-
ing with CD14-phycoerythrin (PE) mouse anti-human monoclonal antibody (Life
Technologies, Staley Road Grand Island, NY) and ﬂuorescence activated cell sorting
(FACS) analysis. The recovery of monocytes was also evaluated by trypan blue
staining and cells were counted using a Zeiss microscope (Jena, Germany).
CD14þ monocytes had a purity of 85.43  0.26% (mean  SE, n ¼ 60,
81.0e89.1). Consequently, CD14þ adherent macrophages expressing one of a broad
range of plasma membrane receptors, such as mannose receptor (CD206), could be
obtained from these cells [22]. Monocytes were resuspended in RPMI-1640 medium
(Sigma-Aldrich, Oakville, Ontario, Canada) supplemented with 25 mM HEPES
Table 1. Functional characteristics of chemical agents used.
Chemical agents Functions
Rottlerin Protein kinase C inhibitor
TAPI-1 Disintegrin and metalloproteinase inhibitor





Aprepitant Substance P/NK-1 receptor antagonists
Akt: Protein kinase B; ROCK: Rho-associated coiled-coil forming kinase; NK-1: Neurokinin 1; ERK:
Extracellular signal-regulated kinase.
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(Sigma-Aldrich), 100 mM/L L-glutamine (Sigma-Aldrich), 100 U/mL penicillin,
and 100 mg/mL streptomycin (Sigma-Aldrich).
2.4. Induction of macrophages from adherent monocytes
CD14þ adherent monocytes were seeded at 1 106 cells/mL into 12-well tissue cul-
ture plates containing RPMI-1640 medium with 10% FCS and 4 mM L-glutamine,
and were incubated in the presence of 10  103 ng/L recombinant human GM-CSF
[23]. On day 1, 3 and 6, the cells were washed and then fresh media containing GM-
CSF was added. GM-CSF-dependent macrophages (on 9 day of culture) were uti-
lized as M1 macrophages in this study.
2.5. Enzyme-linked immunosorbent assay (ELISA) for RANTES
M1 macrophages were exposed to SP (0, 1 or 5 mM) with or without aprepitant (40
nM) for 6 hr and then protein levels of RANTES in whole-cell lysates were
measured by ELISA (R&D Systems, Minneapolis, MN) with an anti-RANTES
monoclonal antibody.
2.6. Identifying the intracellular signaling pathway for RANTES
production
M1 macrophages were pretreated with PD98059 (10 mM), SB203580 (10 mM),
BIRB796 (20 mM) or U0126 (60 mM) and then were stimulated for 6 hr with SP
(5 mM). Then RANTES protein levels in whole-cell lysates were determined by
ELISA (Abcam Inc.).
2.7. Extraction of RNA and ampliﬁcation of RANTES
M1macrophages (on day9 of culture)were stimulatedwith SP (0, 5, 10 or 20mM) for 6
hr, after which macrophages (1 106 cells) were extracted with 1 mL of Isogen RNA
kit (NipponGene, Toyama, Japan). Total RNAwas isolated and precipitated according
to the manufacturer’s instructions, after which 200 ng of total RNA was reverse-
transcribed using Oligo dT primer with a PrimeScript RT reagent Kit (Takara Bio,
Shiga, Japan). Then the reverse-transcribed RNA was ampliﬁed by the polymerase
chain reaction (PCR) using a TaKaRa PCR thermal cycler (Takara Bio, Shiga, Japan).
Subsequently, human RANTES was ampliﬁed from genomic DNA by the reverse
transcriptase-polymerase chain reaction (RT-PCR) using the following primers: 50-
CTACTCGGGAGGCTAAGGCAGGAA-30 (forward for RANTES), 50-GAGGGGT
TGAGACGGCGGAAGC-30 (reverse for RANTES), 50-GTGGGGCGCCCCAGG-
CACCA-30 (forward for b-actin), and 50-CTCCTTAATGTCACGCACGATTTC-30
(reverse for b-actin).
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2.8. Luciferase reporter gene assay
The luciferase reporter gene assay was performed as described previously [24]. A
RANTES promoter-luciferase reporter plasmid was obtained from Takara Bio Inc.
(Shiga, Japan). Macrophages were transiently transfected with either this plasmid
(RANTES) or the empty vector (Mock) using lipofectamine 2000 (Invitrogen, Carls-
bad CA) on day 7 of culture [25]. Then macrophages were stimulated for 6 hr with
substance P (0, 5, 10 or 20 mM) on day 9 of culture, and cellular extracts were pre-
pared for the luciferase enzyme assay. To determine luciferase activity, 25 mL of
Bright-Glo (Promega, Madison, WI) was added to the cells, and luminescence
was measured using a TriLux luminescence counter (Perkin-Elmer Life Sciences,
Rodgau, Germany) after incubation for 2 min at 37 C.
2.9. Transfection of macrophages with small interfering RNA
(siRNA)
Small interfering RNA for Sp1, b-arrestin 2, G-protein- coupled receptor kinase 2
(GRK2), transforming growth factor b1/2/3 (TGFb1/2/3), C/EBPb, transcriptional
intermediary factor 1 b (TIF1b) or friend leukemia integration 1 (Fli-1) were ob-
tained from Santa Cruz Biotechnology, Dallas, Texas. Transfection of M1 macro-
phages with siRNA for Sp1 (50 nM), b-arrestin 2 (50 nM), GRK2 (50 nM),
TGFb1/2/3 (50 nM), C/EBPb (50 nM), TIF1b (50 nM) or Fli-1 (50 nM) was per-
formed on days 7e8 of culture according to the manufacturer’s protocol for Lip-
ofectamine RNAiMAX (Life Technologies, Carlsbad, CA). Control siRNA-A
(Santa Cruz Biotechnology) was utilized as the negative control for these
experiments.
2.10. Eﬀect of b-arrestin 2 siRNA, GRK2 siRNA, dynasore,
Y-27632, or TGFb1/2/3 siRNA on RANTES expression
To determine the role of b-arrestin 2, GRK2, dynamin, ROCK, and TGFb1 in
signaling during internalization of NK1R, we investigated the eﬀect of b-ar-
restin 2 siRNA, GRK2 siRNA, TGFb1/2/3 siRNA, or dynasore (a dynamin in-
hibitor) or Y-27632 (a ROCK inhibitor) on the expression of RANTES by
macrophages after exposure to SP. M1 macrophages transfected with b-arrestin
2 siRNA (50 nM), GRK2 siRNA (50 nM), or TGFb1/2/3 siRNA (50 nM) and
macrophages pretreated with dynasore (10 mM) or Y-27632 (10 mM) were stim-
ulated with SP (5 mM) for 6 hr, after which RANTES protein levels were
measured by ELISA.
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2.11. Eﬀect of mithramycin (a gene-speciﬁc Sp1 inhibitor), Sp1
siRNA, C/EBPb siRNA, or TGFb1/2/3 siRNA on expression of
TGFb1 or RANTES
M1 macrophages (on day 9 of culture) were pretreated with mithramycin (1, 2, or 5
nM) for 6 hr or were transfected with Sp1 siRNA, C/EBPb siRNA, or TGFb1/2/3
siRNA. Then the cells were stimulated with SP (5 mM) for 6 hr, after which latency-
associated peptide (LAP: TGFb1) or RANTES proteins were detected by ELISA.
2.12. Eﬀect of silencing Sp1, C/EBPb, TIF1b, or Fli-1 onRANTES
expression by M1 macrophages after stimulation with SP
M1 macrophages were transfected with siRNA for Sp1, C/EBPb, TIF1b, or Fli-1
and then were stimulated with SP (5 mM) for 6 hr, after which RANTES protein
was determined in whole-cell lysates by ELISA.
2.13. Western blotting for TGFb1
M1 macrophages were transfected with siRNA for Sp1, TGFb1/2/3 or C/EBPb.
Then TGFb1 protein production by the transfected cells was detected by western
blotting of whole-cell lysates with an anti-mouse monoclonal antibody for TGFb1
(Santa Cruz Biotechnology, Santa Cruz, CA). Whole-cell lysates of M1 macro-
phages stimulated with human recombinant TNFa (1 ng) for 6 hr were utilized as
Fig. 1. Eﬀect of SP on RANTES production by M1 macrophages. M1 macrophages (day 9 of culture)
were stimulated with SP (5 mM) for 6 hr in the presence or absence of aprepitant. Then RANTES protein
levels in whole-cell lysates were determined by ELISA. Data were obtained using macrophages from
three individuals in each group and represent the mean  SE. **P < .01 (with Bonferroni’s correction).
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the positive control. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was
also detected by western blotting with an anti-GAPDH antibody (Santa Cruz
Biotechnology).
2.14. Statistical analysis
Results are expressed as the mean  SE. Analysis of variance and the t-test for in-
dependent means were used to assess diﬀerences between multiple groups and dif-
ferences between two groups, respectively. When the F ratio was found to be
signiﬁcant, mean values were compared by using a post hoc Bonferroni test. A prob-
ability (P) value < 0.05 was considered to indicate signiﬁcance in all analyses.
3. Results
Stimulation with SP upregulated RANTES production by human M1 macrophages
in a concentration-dependent manner compared with untreated control cells. This
Fig. 2. Expression of RANTES mRNA and luciferase enzyme assay. Expression of RANTES mRNA
after stimulation of macrophages with SP was detected by the reverse transcription polymerase chain re-
action (RT-PCR). The density of the RANTES band was normalized to that of the b-actin band. (a)
Representative RT-PCR (b) Densitometric data. Luciferase activity in unstimulated cells transfected
with the reporter plasmid alone (Mock) was set as 1.0. (c) Relative luciferase activity. Data were obtained
using macrophages from three individuals in each group and represent the mean  SE. **P < .01;
*P < .05 (with Bonferroni’s correction); N.S., not signiﬁcant.
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response was blunted by aprepitant, which is an NK1R antagonist (Fig. 1). SP
caused upregulation of the relative level of RANTES mRNA. In the luciferase re-
porter gene assay, relative luciferase activity was increased in a concentration-
dependent manner by stimulation with SP (Fig. 2). Interestingly, pretreatment
with BIRB796 (a p38g/p38d MAPK inhibitor) signiﬁcantly decreased the expres-
sion of RANTES protein by SP-stimulated macrophages, while neither SB203580
(a p38a/p38b inhibitor) nor PD98059 (an ERK1 inhibitor) aﬀected RANTES
expression after SP stimulation. High concentrations of U0126 (an ERK1/2 inhibi-
tor) also had no eﬀect on RANTES production (Fig. 3). Next, we investigated the
role of b-arrestin 2, GRK2, dynamin, ROCK, and TGFb1, which are associated
with NK1R internalization and traﬃcking, in signal transduction associated with
RANTES expression. Accordingly, we assessed the eﬀect of b-arrestin 2 siRNA,
GRK2 siRNA, or TGFb1/2/3 siRNA, dynasore (a dynamin inhibitor) or Y-27632
(a ROCK inhibitor) on RANTES protein levels after exposure of macrophages to
SP. Unexpectedly, b-arrestin 2 siRNA and GRK2 siRNA signiﬁcantly upregulated
RANTES protein production, whereas TGFb1/2/3 siRNA or dynasore attenuated it
and Y-27632 had no eﬀect (Fig. 4).
Fig. 3. Eﬀect of PD98059, SB203580, BIRB796, or U0126 on RANTES production by M1 macro-
phages stimulated with SP. M1 macrophages day 9 of culture were pretreated with PD98059,
SB203580, BIRB796, or U0126 and then were stimulated with SP for 6 hr, after which RANTES protein
levels in whole-cell lysates were determined by ELISA. Data were obtained by using cells from three
diﬀerent donors in each group and represent the mean  SE. **P < .01; *P < .05 (with Bonferroni’s
correction); N.S., not signiﬁcant.
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Interestingly, silencing of Sp1 signiﬁcantly enhanced the TGFb1 protein level after
exposure of macrophages to SP. We also investigated the eﬀect of mithramycin (an
inhibitor of DNA binding by Sp1 family members) on TGFb1 expression after SP
stimulation, revealing that inhibition of Sp1 activity by mithramycin signiﬁcantly
increased the TGFb1 protein level in a concentration-dependent manner. Surpris-
ingly, C/EBPb siRNA attenuated TGFb1 production, unlike Sp1 siRNA (Fig. 5).
Western blotting also demonstrated the enhancement of TGFb1 expression by
Sp1 siRNA or mithramycin, but not by C/EBPb siRNA (Fig. 6).
Sp1 siRNA signiﬁcantly upregulated RANTES protein production by macrophages
after exposure to SP compared to untreated control cells. Mithramycin also enhanced
the RANTES protein level in a concentration-dependent manner, but silencing of
C/EBPb attenuated RANTES production in response to SP (Fig. 7). We also inves-
tigated the role of cross-talk among transcription factors (between Sp1 and C/EBPb,
TIF1b, or Fli-1) in RANTES expression by performing double transfection.
Compared with TIF1b siRNA or Fli-1 siRNA, we found that C/EBPb siRNA
Fig. 4. Eﬀect of b-arrestin 2 siRNA, GRK2 siRNA, dynasore, Y-27632, or TGFb1/2/3 siRNA on
RANTES expression by M1 macrophages after exposure to SP. M1 macrophages (day 9 of culture) trans-
fected with b-arrestin 2 sRNA, GRK2 siRNA, or TGFb1/2/3 siRNA and macrophages pretreated with
dynasore (10 mM) or Y-27632 (10 mM) were stimulated with SP (5 mM) for 6 hr, after which RANTES
protein levels were measured by ELISA. Data were obtained by using cells from three diﬀerent donors in
each group and represent the mean  SE. **P < .01; *P < .05 (with Bonferroni’s correction).
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signiﬁcantly inhibited RANTES production by Sp1 siRNA-transfected macrophages
after SP stimulation (Fig. 8). Fig. 9 displays the proposed protein-protein interactions
and signaling pathways addressed in this study.
4. Discussion
The role of SP in regulating expression of the atherogenic chemokine RANTES by
human M1 macrophages is poorly understood. The present study demonstrated that
SP upregulated RANTES production by macrophages in a concentration-dependent
manner, whereas aprepitant (which inhibits NK1R) blunted this response. SP has
previously been shown to increase phosphorylation of p38MAPK and ERK1/2
[26]. However, we found that RANTES production in response to SP stimulation
was signiﬁcantly blunted by BIRB796 (a p38g/p38d inhibitor).
Delayed internalization of NK1R has been shown to enhance its signaling [17].
TGFb1 has been reported to delay SP-induced NK1R internalization [16], resulting
Fig. 5. Eﬀect of mithramycin, Sp1 siRNA, C/EBPb siRNA, or TGFb1/2/3 siRNA on TGFb1 expression
by SP-stimulated M1 macrophages. M1 macrophages (day 9 of culture) pretreated with mithramycin (0,
1, 2, or 5 nM) and macrophages transfected with Sp1 siRNA, C/EBPb siRNA, or TGFb1/2/3 siRNA
were stimulated with SP (5 mM) for 6 hr. Then TGFb1 protein levels in whole-cell lysates were measured
by ELISA. Data were obtained by using cells from three diﬀerent donors in each group and represent the
mean  SE. **P < .01; *P < .05 (with Bonferroni’s correction).
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in enhancement of signaling by SP [17]. This study also showed that SP upregulated
TGFb1 in macrophages exposed to SP with corresponding enhancement of
RANTES protein expression. Interestingly, this enhancement of RANTES produc-
tion was blunted by TGFb1/2/3 siRNA, which implies that TGFb1 promotes
RANTES expression via SP-mediated activation of NK1R. Both transcription factor
Sp1 and C/EBPb are known to be promoters of TGFb1 [19, 20]. Therefore, we
investigated the eﬀect of Sp1 or C/EBPb on TGFb1 protein production by macro-
phages stimulated with SP. Unexpectedly, silencing of Sp1 signiﬁcantly upregulated
TGFb1 expression and consequently increased the RANTES protein level in SP-
stimulated macrophages. Moreover, inhibition of Sp1 activity by mithramycin
augmented both TGFb1 and RANTES protein expression in a concentration-
dependent manner. Mithramycin is a gene-selective Sp1 inhibitor that binds to
GC-rich DNA sequences and displaces Sp1 [27] or modulates Sp1 protein by
proteasome-dependent degradation [28]. Several cytokine/chemokine genes are
induced or repressed by the transcription factor C/EBPb. In the present study, we
found that TGFb1 production was inhibited by C/EBPb siRNA. Activated p38
MAPK regulates C/EBPb via phosphorylation [29], and this study revealed that
SP promoted TGFb1 expression via the NK1R/p38gdMAPK/C/EBPb signaling
pathway. Thus, Sp1 and C/EBPb had opposing eﬀects on TGFb1 expression.
Fig. 6. Western blotting for detection of TGFb1. After pretreatment of M1 macrophages (day 9 of cul-
ture) with mithramycin (5 nM) or transfection with Sp1 siRNA, C/EBPb siRNA or TGFb1/2/3 siRNA,
the cells were stimulated with SP (5 mM) for 6 hr. Then TGFb1 protein was detected by western blotting
of whole-cell lysates. Whole-cell lysates of M1 macrophages stimulated with recombinant TNFa (1 ng)
for 6 hr were utilized as the positive control. The density of the TNFb1 band was normalized to that of
GAPDH. Samples were tested in triplicate and three separate experiments were performed. (a) Represen-
tative western blot. (b) Densitometry data.
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Cross-talk among transcription factors pathways is extremely complex, with tandem
combinations of transcription factors variously being inert or having additive, syn-
ergistic, or antagonistic eﬀects. C/EBP-b binds to a number of response elements
and forms heteromeric complexes with other transcription factors such as Sp1.
Indeed, the C/EBPb promoter contains a TATA box and binding sites for several
transcription factors that regulate C/EBPb mRNA expression, including C/EBPb it-
self [30], signal transducer and activator of transcription 3 (STAT3) [31], and Sp1
[32]. In this study, we demonstrated that C/EBPb siRNA attenuated TGFb1 protein
production, whereas it was increased by Sp1 siRNA. Moreover, it has been reported
that C/EBPb shows synergistic transcriptional activation of the CYP2D5 P-450 gene
with Sp1 [33]. On the other hand, cross-talk between Sp1 and C/EBPb has the oppo-
site eﬀect on induction of tumor suppressor ARF [34].
The human RANTES promoter region contains a wide variety of transcription
factor-binding sites, including sites for CCAAT-enhancer-binding protein
Fig. 7. Eﬀect of mithramycin, Sp1 siRNA, C/EBPb siRNA, or TGFb1/2/3 siRNA on RANTES expres-
sion by M1 macrophages exposed to SP. M1 macrophages (day 9 of culture) pretreated with mithramycin
(0, 1, 2, or 5 nM) and macrophages transfected with Sp1 siRNA, C/EBPb siRNA, or TGFb1/2/3 siRNA
were stimulated with SP (5 mM) for 6 hr. Then RANTES protein levels in whole-cell lysates were
measured by ELISA. Data were obtained by using cells from three diﬀerent donors in each group and
represent the mean  SE. **P < .01; *P < .05 (with Bonferroni’s correction).
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(C/EBP) and friend leukemia integration 1 (Fli-1) [35]. Transcriptional intermediary
factor 1 beta (TIF1b) was reported to act as a coactivator of C/EBPb [36]. Therefore,
we investigated the inﬂuence of transcriptional cross-talk between Sp1 and C/EBPb,
Fli-1, or TIF1b on RANTES expression by SP-stimulated macrophages. Double
transfection of macrophages with Sp1 and C/EBPb siRNA showed a signiﬁcantly
greater inhibitory eﬀect on RANTES production after exposure to SP, compared
with transfection of Fli-1 or TIF1b siRNA. Importantly, double transfection of mac-
rophages with Sp1 and C/EBPb siRNA reduced the TGFb1 protein level after expo-
sure to SP. These results suggest that SP1 and C/EBPb are negative and positive
regulators of TGFb1 expression, respectively, implying antagonistic cross-talk be-
tween these factors.
Obesity is associated with vascular diseases that are often attributed to oxidative
stress [37], and prolonged endoplasmic reticulum stress leads to increased
Fig. 8. Eﬀect of silencing Sp1, C/EBPb, TIF1b, or Fli-1 on RANTES expression by SP-stimulated M1
macrophages. M1 macrophages (day 9 of culture) transfected with Sp1 siRNA, C/EBPb siRNA, TIF1b
siRNA, or Fli-1 siRNA or macrophages transfected with Sp1 siRNAþ C/EBPb siRNA, Sp1 siRNAþ
TIF1b siRNA, or Sp1 siRNAþ Fli-1 siRNA were stimulated with SP for 6 hr. Then RANTES protein
levels were measured by ELISA. Data were obtained by using cells from three diﬀerent donors in each
group and represent the mean  SE. **P < .01; *P < .05 (with Bonferroni’s correction); N.S. not
signiﬁcant.
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production of reactive oxygen species. C/EBPb is highly expressed by macrophages
and regulates NADPH oxidases, which are involved in one of the basic pathogenetic
processes of atherosclerosis. The present study revealed that SP promoted TGFb1
expression via the NK1R/p38gd MAPK/C/EBPb signaling pathway, resulting in
enhanced production of RANTES through TGFb1-induced delay of NK1R internal-
ization and consequent enhancement of SP signaling. Interestingly, we found that
Sp1/C/EBPb cross-talk inhibited the increase of RANTES expression in response
to SP, which may imply a link between obesity and regulation of atherogenic
RANTES expression via C/EBPb.
In conclusion, the transcription factor Sp1 is involved in cross-talk with C/EBPb and
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Fig. 9. Proposed mechanisms by which transcription factor speciﬁcity protein 1 modulates TGFb1 pro-
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tion of TGFb1 via cross-talk with C/EBPb, thus inﬂuencing RANTES expression by macrophages after
stimulation with SP.
15 https://doi.org/10.1016/j.heliyon.2018.e00679
2405-8440/ 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Article Nowe00679
Reona Yamaguchi: Conceived and designed the experiments; Analyzed and inter-
preted the data.
Shinji Narahara, Hiroyuki Sugiuchi: Performed the experiments.
Funding statement
This work was partly supported by a Kumamoto Health Science University special
fellowship grant (No. 27-A-1 and 2016-C-15).
Competing interest statement
The authors declare no conﬂict of interest.
Additional information
No additional information is available for this paper.
References
[1] G. Fantuzzi, T. Mazzone, Adipose tissue and atherosclerosis: exploring the
connection, Arterioscler. Thromb. Vasc. Biol. 27 (2007) 996e1003.
[2] G. Chinetti-Gbaguidi, S. Colin, B. Staels, Macrophage subsets in atheroscle-
rosis, Nat. Rev. Cardiol. 12 (2015) 10e17.
[3] J.L. St€oger, M.J. Gijbels, S. van der Velden, M. Manca, C.M. van der Loos,
E.A. Biessen, M.J. Daemen, E. Lutgens, M.P. de Winther, Distribution of
macrophage polarization markers in human atherosclerosis, Atherosclerosis
225 (2012) 461e468.
[4] A. Louvet, F. Teixeira-Clerc, M.N. Chobert, V. Deveaux, C. Pavoine,
A. Zimmer, F. Pecker, A. Mallat, S. Lotersztajn, Cannabinoid CB2 receptors
protect against alcoholic liver disease by regulating Kupﬀer cell polarization in
mice, Hepatology 54 (2011) 1217e1226.
[5] H. Liu, H. Ning, H. Men, R. Hou, M. Fu, H. Zhang, J. Liu, Regulation of
CCL5 expression in smooth muscle cells following arterial injury, PLoS
One 7 (2012), e30873.
[6] I. Karagiannides, K. Bakirtzi, E. Kokkotou, D. Stavrakis, K.G. Margolis,
T. Thomou, N. Giorgadze, J.L. Kirkland, C. Pothoulakis, Role of substance
P in the regulation of glucose metabolism via insulin signaling-associated
pathways, Endocrinology 152 (2011) 4571e4580.
16 https://doi.org/10.1016/j.heliyon.2018.e00679
2405-8440/ 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Article Nowe00679
[7] M.J. Dubon, Y. Byeon, K.S. Park, Substance P enhances the activation of
AMPK and cellular lipid accumulation in 3T3-L1 cells in response to high
levels of glucose, Mol. Med. Rep. 12 (2015) 8048e8054.
[8] I. Karagiannides, C. Pothoulakis, Substance P, obesity, and gut inﬂammation,
Curr. Opin. Endocrinol. Diabetes Obes. 16 (2009) 47e52.
[9] R. Yamaguchi, T. Yamamoto, A. Sakamoto, Y. Ishimaru, S. Narahara,
H. Sugiuchi, Y. Yamaguchi, Substance P enhances tissue factor release
from granulocyte-macrophage colony-stimulating factor-dependent macro-
phages via the p22phox/b-arrestin 2/Rho A signaling pathway, Blood Cells
Mol. Dis. 57 (2016) 85e90.
[10] J. Sun, R.D. Ramnath, M. Bhatia, Neuropeptide substance P upregulates che-
mokine and chemokine receptor expression in primary mouse neutrophils,
Am. J. Physiol. Cell Physiol. 293 (2007) C696eC704.
[11] F. Schmidlin, O. Dery, K.O. DeFea, L. Slice, S. Patierno, C. Sternini,
E.F. Grady, N.W. Bunnett, Dynamin and Rab5a-dependent traﬃcking and
signaling of the neurokinin 1 receptor, J. Biol. Chem. 276 (2001)
25427e25437.
[12] S.M. Ferguson, P. De Camilli, Dynamin, a membrane-remodelling GTPase,
Nat. Rev. Mol. Cell Biol. 13 (2012) 75e88.
[13] S. Morlot, A. Roux, Mechanics of dynamin-mediated membrane ﬁssion,
Annu. Rev. Biophys. 42 (2013) 629e649.
[14] K. McConalogue, O. Dery, M. Lovett, H. Wong, J.H. Walsh, E.F. Grady,
N.W. Bunnett, Substance P-induced traﬃcking of beta-arrestins. The role of
beta-arrestins in endocytosis of the neurokinin-1 receptor, J. Biol. Chem.
274 (1999) 16257e16268.
[15] M. Beinborn, A. Blum, L. Hang, T. Setiawan, J.C. Schroeder, K. Stoyanoﬀ,
J. Leung, J.V. Weinstock, TGF-beta regulates T-cell neurokinin-1 receptor
internalization and function, Proc. Natl. Acad. Sci. U. S. A 107 (2010)
4293e4298.
[16] S.L. Roux, G. Borbely, M. S1oniecka, L.J. Backman, P. Danielson, Transform-
ing growth factor beta 1 modulates the functional expression of the
neurokinin-1 receptor in human keratocytes, Curr. Eye Res. 41 (2016)
1035e1043.
[17] S.D. Douglas, S.E. Leeman, Neurokinin-1 receptor: functional signiﬁcance in
the immune system in reference to selected infections and inﬂammation, Ann.
N.Y. Acad. 1217 (2011) 83e95.
17 https://doi.org/10.1016/j.heliyon.2018.e00679
2405-8440/ 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Article Nowe00679
[18] G. Fong, L.J. Backman, H. Alfredson, A. Scott, P. Danielson, The eﬀects of
substance P and acetylcholine on human tenocyte proliferation converge
mechanistically via TGF-b1, PLoS One 12 (2017), e0174101.
[19] L.D. Presser, S. McRae, G. Waris, Activation of TGF-b1 promoter by hepa-
titis C virus-induced AP-1 and Sp1: role of TGF-b1 in hepatic stellate cell acti-
vation and invasion, PLoS One 8 (2013), e56367.
[20] S. Abraham, T. Sweet, K. Khalili, B.E. Sawaya, S. Amini, Evidence for acti-
vation of the TGF-beta1 promoter by C/EBPbeta and its modulation by
Smads, J. Interf. 29 (2009) 1e7.
[21] R.M. Strieter, D.G. Remick, J.P. Lynch 3rd, M. Genord, C. Raiford,
R. Spengler, S.L. Kunkel, Diﬀerential regulation of tumor necrosis factor-
alpha in human alveolar macrophages and peripheral blood monocytes: a
cellular and molecular analysis, Am. J. Respir. Cell Mol. Biol. 1 (1989)
57e63.
[22] R. Yamaguchi, T. Yamamoto, A. Sakamot, Y. Ishimar, S. Narahar,
H. Sugiuchi, E. Hirose, Y. Yamaguchi, Mechanism of interleukin-13 produc-
tion by granulocyte-macrophage colony-stimulating factor-dependent macro-
phages via protease-activated receptor-2, Blood Cells Mol. Dis. 2015 (55)
(2015) 21e26.
[23] R. Yamaguchi, A. Sakamoto, T. Yamamoto, Y. Ishimaru, S. Narahara,
H. Sugiuchi, Y. Yamaguchi, Surfactant protein D inhibits interleukin-12p40
production by macrophages through the SIRPa/ROCK/ERK signaling
pathway, Am. J. Med. Sci. 353 (2017) 559e567.
[24] F. Hirano, A. Kobayashi, Y. Hirano, Y. Nomura, E. Fukawa, I. Makino,
Thrombin-induced expression of RANTES mRNA through protease activated
receptor-1 in human synovial ﬁbroblasts, Ann. Rheum. Dis. 61 (2002)
834e837.
[25] A. Ignatov, J. Robert, C. Gregory-Evans, H.C. Schaller, RANTES stimulates
Ca2þ mobilization and inositol trisphosphate (IP3) formation in cells trans-
fected with G protein-coupled receptor 75, Br. J. Pharmacol. 149 (2006)
490e497.
[26] S. Chakraborty, Z. Nepiyushchikh, M.J. Davis, D.C. Zawieja,
M. Muthuchamy, Substance P activates both contractile and inﬂammatory
pathways in lymphatics through the neurokinin receptors NK1R and NK3R,
Microcirculation 18 (2011) 24e35.
[27] S.F. Sleiman, B.C. Langley, M. Basso, J. Berlin, L. Xia, J.B. Payappilly,
M.K. Kharel, H. Guo, J.L. Marsh, L.M. Thompson, L. Mahishi, P. Ahuja,
18 https://doi.org/10.1016/j.heliyon.2018.e00679
2405-8440/ 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Article Nowe00679
W.R. MacLellan, D.H. Geschwind, G. Coppola, J. Rohr, R.R. Ratan, Mithra-
mycin is a gene-selective Sp1 inhibitor that identiﬁes a biological intersection
between cancer and neurodegeneration, J. Neurosci. 31 (2011) 6858e6870.
[28] E.S. Cho, J.S. Nam, J.Y. Jung, N.P. Cho, S.D. Cho, Modulation of speciﬁcity
protein 1 by mithramycin A as a novel therapeutic strategy for cervical cancer,
Sci. Rep. 4 (2014) 7162.
[29] C. Ambrosino, T. Iwata, C. Scafoglio, M. Mallardo, R. Klein, A.R. Nebreda,
TEF-1 and C/EBPbeta are major p38alpha MAPK-regulated transcription fac-
tors in proliferating cardiomyocytes, Biochem. J. 396 (2006) 163e172.
[30] P. Foka, S. Kousteni, D.P. Ramji, Molecular characterization of the Xenopus
CCAAT-enhancer binding protein beta gene promoter, Biochem. Biophys.
Res. Commun. 285 (2001) 430e436.
[31] M. Niehof, K. Streetz, T. Rakemann, S.C. Bischoﬀ, M.P. Manns, F. Horn,
C. Trautwein, Interleukin-6-induced tethering of STAT3 to the LAP/C/EBP-
beta promoter suggests a new mechanism of transcriptional regulation by
STAT3, J. Biol. Chem. 276 (2001) 9016e9027.
[32] A. Berrier, G. Siu, K. Calame, Transcription of a minimal promoter from the
NF-IL6 gene is regulated by CREB/ATF and SP1 proteins in U937 promon-
ocytic cells, J. Immunol. 161 (1998) 2267e2275.
[33] Y.H. Lee, S.C. Williams, M. Baer, E. Sterneck, F.J. Gonzalez, P.F. Johnson,
The ability of C/EBP beta but not C/EBP alpha to synergize with an Sp1 pro-
tein is speciﬁed by the leucine zipper and activation domain, Mol. Cell Biol.
17 (1997) 2038e2047.
[34] Y. Zheng, C. Devitt, J. Liu, N. Iqbal, S.X. Skapek, Arf induction by Tgfb is
inﬂuenced by Sp1 and C/ebpb in opposing directions, PLoS One 8 (2013),
e70371.
[35] M.L. Lennard Richard, S. Sato, E. Suzuki, S. Williams, T.K. Nowling,
X.K. Zhang, The Fli-1 transcription factor regulates the expression of
CCL5/RANTES, J. Immunol. 193 (2014) 2661e2668.
[36] J.W. Rooney, K.L. Calame, TIF1beta functions as a coactivator for C/EBPbeta
and is required for induced diﬀerentiation in the myelomonocytic cell line
U937, Genes Dev. 15 (2001) 3023e3038.
[37] J.Y. Youn, K.L. Siu, H.E. Lob, H. Itani, D.G. Harrison, H. Cai, Role of
vascular oxidative stress in obesity and metabolic syndrome, Diabetes 63
(2014) 2344e2355.
19 https://doi.org/10.1016/j.heliyon.2018.e00679
2405-8440/ 2018 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
Article Nowe00679
